Article Text

Download PDFPDF

Validation of the German Diabetes Risk Score among the general adult population: findings from the German Health Interview and Examination Surveys
  1. Rebecca Paprott1,2,
  2. Kristin Mühlenbruch2,3,
  3. Gert B M Mensink1,
  4. Silke Thiele4,
  5. Matthias B Schulze2,3,
  6. Christa Scheidt-Nave1,2,
  7. Christin Heidemann1,2
  1. 1Department of Epidemiology and Health Monitoring, Robert Koch Institute, Berlin, Germany
  2. 2German Center for Diabetes Research (DZD), München-Neuherberg, Germany
  3. 3Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany
  4. 4Department of Food Economics and Consumption Studies, Christian-Albrechts-University Kiel, Kiel, Germany
  1. Correspondence to Dr Christin Heidemann; heidemannc{at}rki.de

Abstract

Objective To evaluate the German Diabetes Risk Score (GDRS) among the general adult German population for prediction of incident type 2 diabetes and detection of prevalent undiagnosed diabetes.

Methods The longitudinal sample for prediction of incident diagnosed type 2 diabetes included 3625 persons who participated both in the examination survey in 1997–1999 and the examination survey in 2008–2011. Incident diagnosed type 2 diabetes was defined as first-time physician diagnosis or antidiabetic medication during 5 years of follow-up excluding potential incident type 1 and gestational diabetes. The cross-sectional sample for detection of prevalent undiagnosed diabetes included 6048 participants without diagnosed diabetes of the examination survey in 2008–2011. Prevalent undiagnosed diabetes was defined as glycated haemoglobin ≥6.5% (48 mmol/mol). We assessed discrimination as area under the receiver operating characteristic curve (ROC-AUC (95% CI)) and calibration through calibration plots.

Results In longitudinal analyses, 82 subjects with incident diagnosed type 2 diabetes were identified after 5 years of follow-up. For prediction of incident diagnosed diabetes, the GDRS yielded an ROC-AUC of 0.87 (0.83 to 0.90). Calibration plots indicated excellent prediction for low diabetes risk and overestimation for intermediate and high diabetes risk. When considering the entire follow-up period of 11.9 years (ROC-AUC: 0.84 (0.82 to 0.86)) and including incident undiagnosed diabetes (ROC-AUC: 0.81 (0.78 to 0.84)), discrimination decreased somewhat. A previously simplified paper version of the GDRS yielded a similar predictive ability (ROC-AUC: 0.86 (0.82 to 0.89)). In cross-sectional analyses, 128 subjects with undiagnosed diabetes were identified. For detection of prevalent undiagnosed diabetes, the ROC-AUC was 0.84 (0.81 to 0.86). Again, the simplified version yielded a similar result (ROC-AUC: 0.83 (0.80 to 0.86)).

Conclusions The GDRS might be applied for public health monitoring of diabetes risk in the German adult population. Future research needs to evaluate whether the GDRS is useful to improve diabetes risk awareness and prevention among the general population.

  • A1C
  • Risk Assessment
  • Validation
  • Risk Factor Modeling

This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors CH conceptualized the study. RP analyzed the data and wrote the manuscript. KM and CH supported statistical analyses. KM, GBMM, MBS, ST, CS-N, and CH contributed to interpretation of data and critically revised the manuscript for important intellectual content. All authors read and approved the final version of the manuscript.

  • Funding Both GNHIES98 and DEGS1 were funded by the German Federal Ministry of Health. This study was supported by research grants from the German Federal Ministry of Health (FKZ: GE20130320) and from the German Center for Diabetes Research (DZD) funded by the German Federal Ministry of Education and Research (FKZ: HMGU2015Z1).

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval Charité-Universitätsmedizin Berlin.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data are available.